The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.
Related Posts
Journalists at The Athletic Move to Join New York Times Union
The NewsGuild of New York asked The Times to voluntarily recognize journalists from the sports news website as part of the newsroom’s union.
India’s Drug Makers Shudder as Trump Again Threatens Tariffs
The United States is India’s biggest market for pharmaceutical exports, which are its most successful industrial exports.
Stocks Fall Into a Correction With Investors Down on Trump
The S&P 500 is now more than 10 percent below its last record high — a line in the sand for investors worried about a […]